Psma | search
Click here to view Psma news from 60+ newspapers.
Bookmark or Share- PSMA: A New Target for Prostate Cancer TreatmentPSMA is a protein in prostate cells. Researchers have found that it helps fuel prostate cancer. This offers a new target for prostate cancer treatments. Prostate-specific antigen (PSA) can be an indicator of prostate cancer and is easily detected and measured with a blood test.
- Prostate-specific Membrane Antigen PET in Prostate CancerWith a high detection rate and superior diagnostic accuracy compared with standard imaging, prostate-specific membrane antigen (PSMA) PET is the latest in a series of imaging advancements that are poised to revolutionize the management of prostate cancer.
- PSMA Radiopharmaceutical Effective against Prostate CancerUPDATE: On March 23, 2022, the Food and Drug Administration (FDA) approved Lu177-PSMA-617 (Pluvicto) to treat some adults with metastatic prostate cancer.
- PSMA PET Scan for Prostate Cancer | UCSF RadiologyPSMA PET imaging is a FDA approved scan with more precise detection of prostate cancer for better treatment planning and targeted care. More effective in pinpointing and eliminating tumors not only in the prostate but also throughout the pelvis and the body in cases where the tumors have migrated.
- Advances in PSMA-targeted therapy for prostate cancer - NatureProstate-specific membrane antigen (PSMA), a transmembrane glycoprotein located on the cell membrane, is specifically and highly expressed in prostate cancer (PCa)....
More
